Skip to content

A prospective, multicenter clinical study of the MDT-4113 for the treatment of patients with Severe, Progressive, Life-threatening Early Onset Pediatric Scoliosis:EOS

A prospective, multicenter clinical study of the MDT-4113 for the treatment of patients with Severe, Progressive, Life-threatening Early Onset Pediatric Scoliosis:EOS - A prospective, multicenter clinical study of the MDT-4113 for the treatment of patients with Severe, Progressive, Life-threatening Early Onset Pediatric Scoliosis:EOS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015904
Enrollment
10
Registered
2014-12-10
Start date
2014-09-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Onset Pediatric Scoliosis

Interventions

Implantation of MDT-4113 From operation for MDT-4113 implantation to postoperative 24 months or final fusion operation

Sponsors

Medtronic Sofamor Danek, Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed to severe, progressive, life-threatening Early Onset Scoliosis including congenital scoliosis, juvenile scoliosis, neuromuscular scoliosis and syndromic scoliosis 2. Preoperative major curve Cobb Angle >50 +/-5 degrees (+/-5 degrees is error of measurement) 3. Spinal Curve length over at least 6 segments of the spine 4. Is less than 10 years of age at the time of the index surgery 5. His/her parent or legal guardian has signed the Informed Consent form

Exclusion criteria

Exclusion criteria: 1. Has active infection and/or has significant infectious risk 2. Is diagnosed to allergy or hypersensitivity to metal or is suspect to metal allergy/hypersensitivity 3. General anesthesia is NOT appropriate 4. Operated on spinal fusion with implant(s) 5. Had participated other clinical trial during the last 3 months 6. Has convulsion (If an investigator decides that a patient is not appropriate to enter this study) 7. Has untreated syringomyelia, spinal deformity or spinal cord tumor 8. Reaches skeletal maturity 9. Has inadequate tissue coverage over the operative site 10. Has hypophrenia (If an investigator decides that a patient is not appropriate to enter this study.) 11. Has rib fusion 12. His/her parent or legal guardian has not signed the Informed Consent form

Design outcomes

Primary

MeasureTime frame
Success is defined as a postoperative 24 months major curve Cobb angle less than or equal to 50+/-5 degrees or an improvement of at least 50% compared to preoperative. (+/-5 is error of measurement)

Countries

Japan

Contacts

Public ContactAsami Taguchi

Medtronic Sofamor Danek, Co., Ltd. Regulatory and Clinical Affairs

asami.taguchi@medtronic.com03-6776-0352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026